Skip to content
value.today

Innovative Pulmonary Solutions, Inc.

Total raised
$177 M
9 rounds on record
Latest round
$36 M
Feb 2026
First round on record
Sep 2010
Today
Private
No later event on record

Funding rounds

9 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Innovative Pulmonary Solutions, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2026$36 MNo. 9$10 to $50 million

Innovative Pulmonary Solutions, Inc.: Raise no. 9, Feb 2026

Investors in this round

9 investors had bought by the notice of Mar 4, 2026: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$36 M of $64 M offered; $28 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Conversion of SAFEs; Conversion of debt
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dennis W. Wahr · Executive Officer, Director
  • Edward J. Morgan · Director
  • Geoffrey J. Duyk · Director
  • Timothy W. Herbert · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Excludes standard compensation for officers and directors.”

Signed by Dennis W. Wahr, Chief Executive Officer. Newest notice filed Mar 4, 2026. Read the notice at the SEC.

equitySEC
Nov 2023$15 MNo. 8$10 to $50 million

Innovative Pulmonary Solutions, Inc.: Raise no. 8, Nov 2023

Investors in this round

39 investors had bought by the notice of Dec 1, 2023: 39 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $17 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dennis W. Wahr · Executive Officer, Director
  • Tom A. Griffin · Executive Officer
  • David A. Van Meter · Director
  • Henry A. Plain · Director
  • Jacques A. Essinger · Director
  • Jonathan A. Root · Director
  • Michael A, Carusi · Director
  • Timothy A. Herbert · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Excludes standard compensation for officers and directors.”

Signed by Dennis W. Wahr, Chief Executive Officer. Newest notice filed Dec 1, 2023. Read the notice at the SEC.

equitySEC
Jul 2020$31 MNo. 7$10 to $50 million

Innovative Pulmonary Solutions, Inc.: Raise no. 7, Jul 2020

Investors in this round

49 investors had bought by the notice of Jan 19, 2022: 49 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$31 M of $68 M offered; $37 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dennis W. Wahr · Executive Officer, Director
  • Gary A. Rieschel · Director
  • Henry A. Plain · Director
  • Jonathan A. Root · Director
  • Michael A. Carusi · Director
  • Robert A. O'Holla · Director
  • Tim A. Herbert · Director
  • Yoh-Chie A. Lu · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Excludes standard compensation for officers and directors.”

Signed by Dennis W. Wahr, Chief Executive Officer. Newest notice filed Jan 19, 2022 (2 amendments). Read the notice at the SEC.

equitySEC
Feb 2019$25 MNo. 6$10 to $50 million

Innovative Pulmonary Solutions, Inc.: Raise no. 6, Feb 2019

Investors in this round

20 investors had bought by the notice of Feb 14, 2019: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$25 M of $75 M offered; $50 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dennis W. Wahr · Executive Officer, Director
  • Alexander A. Schmitz · Director
  • Carolyn A. Ng · Director
  • Christopher A. Shen · Director
  • Henry A. Plain · Director
  • Jonathan A. Root · Director
  • Michael A. Carusi · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Dennis W. Wahr, Chief Executive Officer. Newest notice filed Feb 14, 2019. Read the notice at the SEC.

equitySEC
Apr 2018$4 MNo. 5$2 to $10 million

Innovative Pulmonary Solutions, Inc.: Raise no. 5, Apr 2018

Investors in this round

9 investors had bought by the notice of May 15, 2018: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $8 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dennis W. Wahr · Executive Officer, Director
  • Dave W. Stassen · Director
  • Hank W. Plain · Director
  • James W. Lee Tze Wei · Director
  • Kirk W. Nielsen · Director
  • Mark W. Deem · Director
  • Mike W. Carusi · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Excludes standard compensation for officers and directors.”

Signed by Kari Kubesh, Chief Financial Officer. Newest notice filed May 15, 2018. Read the notice at the SEC.

debt, optionsSEC
Apr 2014$42 MNo. 4$10 to $50 million

Innovative Pulmonary Solutions, Inc.: Raise no. 4, Apr 2014

Investors in this round

9 investors had bought by the notice of Apr 7, 2014: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$42 M of $42 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dennis Wahr · Executive Officer, Director
  • Dave Stassen · Director
  • Hank Plain · Director
  • Kirk Nielsen · Director
  • Lincoln Chee · Director
  • Mark Deem · Director
  • Mike Carusi · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kari Kubesh, Cfo. Newest notice filed Apr 7, 2014. Read the notice at the SEC.

equitySEC
Feb 2013$10 MNo. 3$10 to $50 million

Innovative Pulmonary Solutions, Inc.: Raise no. 3, Feb 2013

Investors in this round

5 investors had bought by the notice of Feb 21, 2013: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$580,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dennis W. Wahr · Executive Officer, Director
  • David A. Stassen · Director
  • Henry A. Plain · Director
  • Kirk A. Nielsen · Director
  • Mark A. Deem · Director
  • Michael A. Carusi · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “PROCEEDS MAY BE USED FOR SALARY AND BENEFITS OF DENNIS WAHR, AS CHIEF EXECUTIVE OFFICER, AND TO REIMBURSE EXPENSES FOR THE BOARD OF DIRECTORS”

Signed by Kari Kubesh, Chief Financial Officer. Newest notice filed Feb 21, 2013. Read the notice at the SEC.

equitySEC
Mar 2012$11 MNo. 2$10 to $50 million

Innovative Pulmonary Solutions, Inc.: Raise no. 2, Mar 2012

Investors in this round

16 investors had bought by the notice of Apr 6, 2012: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $11 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Steven Dimmer · Executive Officer, Director
  • David Stassen · Director
  • Henry Plain · Director
  • Kirk Nielsen · Director
  • Mark Deem · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Steven Dimmer, Chief Executive Offier. Newest notice filed Apr 6, 2012. Read the notice at the SEC.

equitySEC
Sep 2010$3 MNo. 1$2 to $10 million

Innovative Pulmonary Solutions, Inc.: Raise no. 1, Sep 2010

Investors in this round

3 investors had bought by the notice of Sep 29, 2010: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $8 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Martin L. Mayse · Executive Officer, Director
  • Steven Dimmer · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Steven Dimmer, Chief Executive Offier. Newest notice filed Sep 29, 2010. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Innovative Pulmonary Solutions, Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2026).

    SEC Form D · Mar 2026

  • The industry group it chose in its notices: Other.

    SEC Form D · Mar 2026

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Innovative Pulmonary Solutions, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Innovative Pulmonary Solutions, Inc.
NameRoleNamed in
Dennis W. WahrExecutive officerMar 2026
Tom A. GriffinExecutive officerDec 2023
Dennis WahrExecutive officerApr 2014
Steven DimmerExecutive officerApr 2012
Martin L. MayseExecutive officerSep 2010
Dennis W. WahrDirectorMar 2026
Edward J. MorganDirectorMar 2026
Geoffrey J. DuykDirectorMar 2026
Timothy W. HerbertDirectorMar 2026
David A. Van MeterDirectorDec 2023
Henry A. PlainDirectorDec 2023
Jacques A. EssingerDirectorDec 2023
Jonathan A. RootDirectorDec 2023
Michael A, CarusiDirectorDec 2023
Timothy A. HerbertDirectorDec 2023
Gary A. RieschelDirectorJan 2022
Michael A. CarusiDirectorJan 2022
Robert A. O'HollaDirectorJan 2022
Tim A. HerbertDirectorJan 2022
Yoh-Chie A. LuDirectorJan 2022
Carolyn A. NgDirectorJan 2021
Alexander A. SchmitzDirectorJul 2020
Christopher A. ShenDirectorJul 2020
Dave W. StassenDirectorMay 2018
Hank W. PlainDirectorMay 2018
James W. Lee Tze WeiDirectorMay 2018
Kirk W. NielsenDirectorMay 2018
Mark W. DeemDirectorMay 2018
Mike W. CarusiDirectorMay 2018
Dave StassenDirectorApr 2014
Dennis WahrDirectorApr 2014
Hank PlainDirectorApr 2014
Kirk NielsenDirectorApr 2014
Lincoln CheeDirectorApr 2014
Mark DeemDirectorApr 2014
Mike CarusiDirectorApr 2014
David A. StassenDirectorFeb 2013
Kirk A. NielsenDirectorFeb 2013
Mark A. DeemDirectorFeb 2013
David StassenDirectorApr 2012